Published in Respirology on April 05, 2009
Advances in the diagnosis and treatment of sarcoidosis. F1000Prime Rep (2014) 0.96
Current and emerging pharmacological treatments for sarcoidosis: a review. Drug Des Devel Ther (2013) 0.94
Refractory multisystem sarcoidosis responding to infliximab therapy. Clin Rheumatol (2012) 0.77
A case series of refractory cutaneous sarcoidosis successfully treated with infliximab. Dermatol Ther (Heidelb) (2012) 0.76
In vivo evaluation of TNF-alpha in the lungs of patients affected by sarcoidosis. Biomed Res Int (2015) 0.75
Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med (2006) 4.20
A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med (2004) 3.33
Sarcoidosis: a comprehensive review and update for the dermatologist: part I. Cutaneous disease. J Am Acad Dermatol (2012) 2.71
Allergic bronchopulmonary aspergillosis in cystic fibrosis--state of the art: Cystic Fibrosis Foundation Consensus Conference. Clin Infect Dis (2003) 2.49
Endobronchial ultrasound for the diagnosis of pulmonary sarcoidosis. Chest (2007) 2.22
A concise review of pulmonary sarcoidosis. Am J Respir Crit Care Med (2010) 1.98
Cardiac sarcoidosis. Am Heart J (2008) 1.89
The treatment of lupus pernio: results of 116 treatment courses in 54 patients. Chest (2008) 1.78
MSG-01: A randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the critical care setting. Clin Infect Dis (2014) 1.78
Cutaneous sarcoidosis. Semin Respir Crit Care Med (2010) 1.69
Pleural effusions in a series of 181 outpatients with sarcoidosis. Chest (2006) 1.50
Neurosarcoidosis: Clinical manifestations, diagnosis and treatment. Presse Med (2012) 1.44
Treatment of sarcoidosis with infliximab. Chest (2005) 1.43
Chronic cutaneous lesions of sarcoidosis. Clin Dermatol (2007) 1.41
Neurosarcoidosis: presentations and management. Neurologist (2010) 1.33
Organizing pneumonia. Am J Med Sci (2008) 1.32
Cellular responses to mycobacterial antigens are present in bronchoalveolar lavage fluid used in the diagnosis of sarcoidosis. Infect Immun (2009) 1.19
A sarcoidosis genetic linkage consortium: the sarcoidosis genetic analysis (SAGA) study. Sarcoidosis Vasc Diffuse Lung Dis (2005) 1.18
The etiologic agent of sarcoidosis: what if there isn't one? Chest (2003) 1.17
Spinal cord neurosarcoidosis. Am J Med Sci (2014) 1.17
The spectrum of biopsy sites for the diagnosis of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis (2005) 1.16
Sarcoidosis associated with an elevated serum CA 125 level: description of a case and a review of the literature. Am J Med Sci (2007) 1.11
Health-related quality of life of persons with sarcoidosis. Chest (2004) 1.08
Pulmonary and psychosocial findings at enrollment in the ACCESS study. Sarcoidosis Vasc Diffuse Lung Dis (2005) 1.07
Treatment of corticosteroid-resistant neurosarcoidosis with a short-course cyclophosphamide regimen. Chest (2003) 1.06
Pharmacotherapy for pulmonary sarcoidosis: a Delphi consensus study. Respir Med (2010) 1.05
Racial and ethnic disparities in sarcoidosis: from genetics to socioeconomics. Clin Chest Med (2006) 1.02
Isolated neurosarcoidosis: case series in 2 sarcoidosis centers. Neurologist (2012) 0.99
The Sarcoidosis Health Questionnaire: a new measure of health-related quality of life. Am J Respir Crit Care Med (2003) 0.97
A new tool to assess sarcoidosis severity. Chest (2006) 0.95
Inflammatory profile and response to anti-tumor necrosis factor therapy in patients with chronic pulmonary sarcoidosis. Clin Vaccine Immunol (2011) 0.95
Successful treatment of lupus pernio with adalimumab. Arch Dermatol (2011) 0.94
Current and emerging pharmacological treatments for sarcoidosis: a review. Drug Des Devel Ther (2013) 0.94
Neurological deficits during treatment with tumor necrosis factor-alpha antagonists. Am J Med Sci (2011) 0.93
Allergic bronchopulmonary aspergillosis. Clin Chest Med (2012) 0.91
Sarcoidosis. Med Clin North Am (2005) 0.91
Neurosarcoidosis. Curr Treat Options Neurol (2013) 0.90
Differences in symptom severity and health status impairment between patients with pulmonary and pulmonary plus extrapulmonary sarcoidosis. Respir Med (2008) 0.89
Thalidomide for chronic sarcoidosis. Chest (2002) 0.88
Low levels of NF-κB/p65 mark anergic CD4+ T cells and correlate with disease severity in sarcoidosis. Clin Vaccine Immunol (2010) 0.88
Sarcoidosis presenting as bilateral vocal cord paralysis from bilateral compression of the recurrent laryngeal nerves from thoracic adenopathy. J Voice (2008) 0.87
Job and industry classifications associated with sarcoidosis in A Case-Control Etiologic Study of Sarcoidosis (ACCESS). J Occup Environ Med (2005) 0.87
Efficacy of short-course, low-dose corticosteroid therapy for acute pulmonary sarcoidosis exacerbations. Am J Med Sci (2010) 0.86
Patient-reported outcome measures for sleep disorders and related problems: clinical and research applications. Chest (2013) 0.86
Pneumocystis jerovecii pneumonia in a patient with untreated chronic lymphocytic leukaemia: a novel case and postulations concerning the mechanism. BMJ Case Rep (2013) 0.85
Use of fluticasone in acute symptomatic pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis (2002) 0.84
A modern series of percutaneous intracavitary instillation of amphotericin B for the treatment of severe hemoptysis from pulmonary aspergilloma. Chest (2013) 0.84
Early steps in the development of a claims-based targeted healthcare safety monitoring system and application to three empirical examples. Drug Saf (2012) 0.84
Impact of systemic corticosteroids on healthcare utilization in patients with sarcoidosis. Am J Med Sci (2011) 0.84
Clinical manifestations, radiographic findings, treatment options, and outcome in sarcoidosis patients with upper respiratory tract involvement. South Med J (2010) 0.83
Efficacy and safety of apremilast in chronic cutaneous sarcoidosis. Arch Dermatol (2011) 0.83
Chronic facial sarcoidosis including lupus pernio: clinical description and proposed scoring systems. Am J Clin Dermatol (2008) 0.83
Pleural effusion caused by trapped lung. South Med J (2003) 0.83
Staple metalloptysis after lung resection for mycetoma: a case report and a review of the literature. Am J Med Sci (2008) 0.83
Relationship of environmental exposures to the clinical phenotype of sarcoidosis. Chest (2005) 0.83
Changes in chest roentgenogram of sarcoidosis patients during a clinical trial of infliximab therapy: comparison of different methods of evaluation. Chest (2009) 0.82
Acute pulmonary exacerbations of sarcoidosis. Chest (2012) 0.82
Valproic acid-induced eosinophilic pleural effusion: a case report and review of the literature. Am J Med Sci (2007) 0.81
Infliximab for chronic cutaneous sarcoidosis: a subset analysis from a double-blind randomized clinical trial. Sarcoidosis Vasc Diffuse Lung Dis (2016) 0.81
Quality of life evaluation in sarcoidosis: current status and future directions. Curr Opin Pulm Med (2008) 0.80
Glutathione S-transferase M1 polymorphism and the risk of lung cancer. Anticancer Res (2003) 0.80
Bird-years as well as pack-years. Chest (2004) 0.80
Relapses of sarcoidosis: what are they and can we predict who will get them? Eur Respir J (2014) 0.79
Validation of claims-based diagnostic codes for idiopathic thrombotic thrombocytopenic purpura in a commercially-insured population. Thromb Haemost (2010) 0.79
Rapid development of sarcoid tenosynovitis. J Clin Rheumatol (2011) 0.79
The effects of fatigue and treatment with methylphenidate on sustained attention in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis (2005) 0.78
Small fiber neuropathy in sarcoidosis: Something beneath the surface. Respir Med (2010) 0.78
Development and testing of item response theory-based item banks and short forms for eye, skin and lung problems in sarcoidosis. Qual Life Res (2013) 0.78
Sarcoidosis: a comprehensive review and update for the dermatologist: part II. Extracutaneous disease. J Am Acad Dermatol (2012) 0.78
Cardiac sarcoidosis: there is no instant replay. Chest (2005) 0.77
Highly active antiretroviral therapy for HIV with tuberculosis: pardon the granuloma. Chest (2002) 0.77
Vaginal involvement in a patient with sarcoidosis. Chest (2010) 0.77
A conceptual model of health-related quality of life in sarcoidosis. Qual Life Res (2013) 0.76
The utility of the chest radiograph in diagnosing exacerbations of pulmonary sarcoidosis. Respirology (2008) 0.76
Sarcoidosis: lost in translation. Respirology (2011) 0.75
Reply to: Monogenic early-onset sarcoidosis is no longer a variant of "idiopathic" sarcoidosis. J Am Acad Dermatol (2013) 0.75
Trouble below the surface. Am J Med (2006) 0.75
How are cancer and connective tissue diseases related to sarcoidosis? Curr Opin Pulm Med (2015) 0.75
Reticuloendothelial system involvement in untreated sarcoidosis patients as assessed by 18F-FDG PET scanning. Sarcoidosis Vasc Diffuse Lung Dis (2016) 0.75
Chronic hypoxemia and paraganglioma: a rare case and discussion of potential mechanisms. Am J Med Sci (2014) 0.75
Clinical phenotypes in sarcoidosis. Curr Opin Pulm Med (2014) 0.75
Distinguishing asthma from sarcoidosis: an approach to a problem that is not always solvable. J Asthma (2012) 0.75
Proceedings of the 2014 AASOG conference. Sarcoidosis Vasc Diffuse Lung Dis (2015) 0.75
Granulomatosis and polyangitis followed by alveolar proteinosis in a 32-year-old woman. Chest (2012) 0.75
Intracavitary voriconazole for the treatment of hemoptysis complicating Pseudallescheria angusta pulmonary mycetomas in fibrocystic sarcoidosis. Med Mycol (2010) 0.75
Interrelationship Between Sleep-Disordered Breathing and Sarcoidosis. Chest (2015) 0.75
Correlation of spleen metabolism assessed by 18F-FDG PET with serum interleukin-2 receptor levels and other biomarkers in patients with untreated sarcoidosis. Nucl Med Commun (2016) 0.75
Tuberculous mediastinal lymphadenitis that evolved into pulmonary tuberculosis following transbronchial needle aspiration. Respirology (2010) 0.75
Methemoglobinemia Caused by Portable Dialysis in the Critically Ill. Crit Care Med (2017) 0.75
A 23-Year-Old Man With Recurrent Hemoptysis. Chest (2015) 0.75
A neutropenic patient with rapidly progressive lung lesion. Chest (2004) 0.75